Dr. Melissa Moore
Honorary
Medical Education
10 Scholarly works
0 Projects
HIGHLIGHTS
2020
Journal article
Effects of a wearable technology-based physical activity intervention on sleep quality in breast cancer survivors: the ACTIVATE Trial
DOI: 10.1007/s11764-020-00930-72019
Journal article
Effects of the ACTIVity And TEchnology (ACTIVATE) intervention on health-related quality of life and fatigue outcomes in breast cancer survivors
DOI: 10.1002/pon.52982019
Journal article
A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial
DOI: 10.1002/cncr.321432018
Journal article
Study design and methods for the ACTIVity And TEchnology (ACTIVATE) trial
DOI: 10.1016/j.cct.2017.10.0152017
Journal article
A qualitative evaluation of breast cancer survivors' acceptance of and preferences for consumer wearable technology activity trackers
DOI: 10.1007/s00520-017-3756-y2017
Journal article
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma
DOI: 10.1007/s12032-017-1031-12017
Conference Proceedings
P2.07-008 Victorian Comprehensive Cancer Centre Lung Cancer Clinical Audit: Collecting the UK National Lung Cancer Audit data from hospitals in Australia
DOI: 10.1016/j.jtho.2016.11.1548
RECENT SCHOLARLY WORKS
2016
Journal article
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations
DOI: 10.1016/j.pathol.2015.11.0022014
Journal article
The Clinical Relevance of Pathologic Subtypes in Metastatic Lung Adenocarcinoma
DOI: 10.1097/JTO.00000000000001502014
Journal article
EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma
DOI: 10.1097/PAT.0000000000000027